Home » Development and characterization of PLGA nanoparticles containing 1,3-dihydroxy-2-methylxanthone with improved antitumor activity on a human breast cancer cell line.
Development and characterization of PLGA nanoparticles containing 1,3-dihydroxy-2-methylxanthone with improved antitumor activity on a human breast cancer cell line.
admin-cespu
Bibliographic reference:
Teixeira, M., Pedro, M., Nascimento, M. S. J., Pinto, M. M. M., & Barbosa, C. M. (2019). Development and characterization of PLGA nanoparticles containing 1,3-dihydroxy-2-methylxanthone with improved antitumor activity on a human breast cancer cell line. Pharmaceutical Development and Technology, 24(9), 1104–1114. https://doi.org/10.1080/10837450.2019.1638398
Teixeira, M., Pedro, M., Nascimento, M. S. J., Pinto, M. M. M., & Barbosa, C. M. (2019). Development and characterization of PLGA nanoparticles containing 1,3-dihydroxy-2-methylxanthone with improved antitumor activity on a human breast cancer cell line. Pharmaceutical Development and Technology, 24(9), 1104–1114. https://doi.org/10.1080/10837450.2019.1638398